Adicet Bio, Inc. Stock-Based Compensation
Adicet Bio, Inc. (ACET) reported Stock-Based Compensation of $1.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- Adicet Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.40M, a 51.72% decline year-over-year.
- Adicet Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.30M, a 59.03% decline year-over-year.
- Adicet Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $5.65M, a 49.75% increase year-over-year.
- Adicet Bio, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.50M, a 63.24% decline year-over-year.
- Adicet Bio, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $14.27M, a 35.83% decline from fiscal 2024.
- Adicet Bio, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $22.23M, a 9.74% increase from fiscal 2023.
- Adicet Bio, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $20.26M, a 18.29% increase from fiscal 2022.
- Adicet Bio, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $17.13M, a 36.89% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.40M 10-Q · filed 2026-08-05 | $2.74M 10-Q · filed 2026-08-05 | $8.35M derived: sum of 3 quarters · filed 2026-08-05 | $10.85M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $1.30M 10-Q · filed 2026-05-13 | $6.95M derived: sum of 2 quarters · filed 2026-05-13 | $9.45M derived: sum of 3 quarters · filed 2026-05-13 | $12.35M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $8.15M derived: sum of 2 quarters · filed 2026-03-12 | $11.05M derived: sum of 3 quarters · filed 2026-08-05 | $14.27M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $2.50M 10-Q · filed 2025-11-05 | $5.40M derived: sum of 2 quarters · filed 2026-08-05 | $8.62M 10-Q · filed 2025-11-05 | $12.35M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $2.90M 10-Q · filed 2026-08-05 | $6.09M 10-Q · filed 2026-08-05 | $9.85M derived: sum of 3 quarters · filed 2026-08-05 | $16.65M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $3.18M 10-Q · filed 2026-05-13 | $6.95M derived: sum of 2 quarters · filed 2026-05-13 | $13.75M derived: sum of 3 quarters · filed 2026-05-13 | $19.75M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $10.57M derived: sum of 2 quarters · filed 2026-03-12 | $16.57M derived: sum of 3 quarters · filed 2026-03-12 | $22.23M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $6.80M 10-Q · filed 2025-11-05 | $12.80M derived: sum of 2 quarters · filed 2025-11-05 | $18.46M 10-Q · filed 2025-11-05 | $23.39M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $6.00M 10-Q · filed 2025-08-07 | $11.68M 10-Q · filed 2025-08-07 | $16.59M derived: sum of 3 quarters · filed 2025-08-07 | $22.15M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $5.68M 10-Q · filed 2025-05-06 | $10.59M derived: sum of 2 quarters · filed 2025-05-06 | $16.15M derived: sum of 3 quarters · filed 2025-05-06 | $21.17M derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $4.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $10.47M derived: sum of 2 quarters · filed 2025-03-06 | $15.49M derived: sum of 3 quarters · filed 2025-03-06 | $20.26M 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | $5.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $10.58M derived: sum of 2 quarters · filed 2024-11-06 | $15.35M 10-Q · filed 2024-11-06 | $19.60M derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | $5.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $9.79M 10-Q · filed 2024-08-13 | $14.04M derived: sum of 3 quarters · filed 2024-08-13 | $18.23M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $4.76M 10-Q · filed 2024-05-14 | $9.02M derived: sum of 2 quarters · filed 2024-05-14 | $13.21M derived: sum of 3 quarters · filed 2024-05-14 | $17.54M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $8.44M derived: sum of 2 quarters · filed 2024-03-19 | $12.78M derived: sum of 3 quarters · filed 2024-03-19 | $17.13M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | $4.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $8.53M derived: sum of 2 quarters · filed 2023-11-08 | $12.88M 10-Q · filed 2023-11-08 | $17.16M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $4.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $8.69M 10-Q · filed 2023-08-09 | $12.96M derived: sum of 3 quarters · filed 2023-08-09 | $15.49M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $4.35M 10-Q · filed 2023-05-09 | $8.63M derived: sum of 2 quarters · filed 2023-05-09 | $11.16M derived: sum of 3 quarters · filed 2023-05-09 | $13.82M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $6.81M derived: sum of 2 quarters · filed 2023-03-15 | $9.47M derived: sum of 3 quarters · filed 2023-03-15 | $12.51M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $2.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $5.19M derived: sum of 2 quarters · filed 2022-11-08 | $8.23M 10-Q · filed 2022-11-08 | $9.88M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $5.70M 10-Q · filed 2022-08-10 | $7.35M derived: sum of 3 quarters · filed 2022-08-10 | $10.31M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $3.04M 10-Q · filed 2022-05-12 | $4.69M derived: sum of 2 quarters · filed 2022-05-12 | $7.66M derived: sum of 3 quarters · filed 2022-05-12 | $8.01M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $4.61M derived: sum of 2 quarters · filed 2022-03-15 | $4.96M derived: sum of 3 quarters · filed 2022-03-15 | $5.26M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $2.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.32M derived: sum of 2 quarters · filed 2021-11-10 | $3.62M 10-Q · filed 2021-11-10 | $3.93M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $351.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $650.00K 10-Q · filed 2021-08-12 | $1.73M 10-Q · filed 2020-07-30 | $960.00K derived: sum of 3 quarters · filed 2021-08-12 | $218.00K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $299.00K 10-Q · filed 2021-05-17 | $975.00K 10-Q · filed 2020-05-07 | $609.00K derived: sum of 2 quarters · filed 2021-05-17 | -$133.00K derived: sum of 3 quarters · filed 2021-05-17 | $811.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$432.00K derived: sum of 2 quarters · filed 2021-03-12 | $512.00K derived: sum of 3 quarters · filed 2021-03-12 | $1.18M 10-K · filed 2021-03-12 | $3.69M 10-K · filed 2020-03-12 | |||
| 2019-09-30 | -$742.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $202.00K derived: sum of 2 quarters · filed 2020-11-05 | $865.00K 10-Q · filed 2020-11-05 | $2.81M 10-Q · filed 2019-11-05 | $1.13M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-06-30 | $944.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $1.61M 10-Q · filed 2020-07-30 | $1.87M derived: sum of 3 quarters · filed 2021-03-12 | $2.50M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-03-31 | $663.00K 10-Q · filed 2020-05-07 | $930.00K derived: sum of 2 quarters · filed 2021-03-12 | $1.56M derived: sum of 3 quarters · filed 2021-03-12 | $1.96M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2018-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $896.00K derived: sum of 2 quarters · filed 2021-03-12 | $1.30M derived: sum of 3 quarters · filed 2021-03-12 | $2.48M 10-K · filed 2021-03-12 | $2.79M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $629.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.03M derived: sum of 2 quarters · filed 2019-11-05 | $2.21M 10-Q · filed 2019-11-05 | $2.38M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $402.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $1.58M 10-Q · filed 2019-08-14 | $1.75M derived: sum of 3 quarters · filed 2020-03-12 | $1.84M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $1.18M 10-Q · filed 2019-05-15 | $1.35M derived: sum of 2 quarters · filed 2020-03-12 | $1.44M derived: sum of 3 quarters · filed 2020-03-12 | $1.53M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $260.00K derived: sum of 2 quarters · filed 2020-03-12 | $345.00K derived: sum of 3 quarters · filed 2020-03-12 | $470.00K 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $176.00K derived: sum of 2 quarters · filed 2018-11-13 | $301.00K 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $210.00K 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | $125.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |